Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Artificial Blood Cells Market Growth 2022-2028

  • RnM4384693
    • |
  • 10 February, 2022
    • |
  • Global
    • |
  • 109 Pages
    • |
  • LPI(LP Information)
    • |
  • Medical Devices & Consumables

As the global economy mends, the 2021 growth of Artificial Blood Cells will have significant change from previous year. According to our (LP Information) latest study, the global Artificial Blood Cells market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Artificial Blood Cells market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Artificial Blood Cells market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Artificial Blood Cells market, reaching US$ million by the year 2028. As for the Europe Artificial Blood Cells landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Artificial Blood Cells players cover Dextro-Sang Corporation, BioPure Corporation, Sangart, and Northfield Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Blood Cells market by product type, application, key manufacturers and key regions and countries.

Segmentation by source: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Animal Hemoglobin
Human Hemoglobin
Stem Cell
Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Cardiovascular Diseases
Anemia
Organ Transplant
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Artificial Blood Cells Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Artificial Blood Cells by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Artificial Blood Cells by Country/Region, 2017, 2022 & 2028
  • 2.2 Artificial Blood Cells Segment by Source
    • 2.2.1 Animal Hemoglobin
    • 2.2.2 Human Hemoglobin
    • 2.2.3 Stem Cell
    • 2.2.4 Others
  • 2.3 Artificial Blood Cells Sales by Source
    • 2.3.1 Global Artificial Blood Cells Sales Market Share by Source (2017-2022)
    • 2.3.2 Global Artificial Blood Cells Revenue and Market Share by Source (2017-2022)
    • 2.3.3 Global Artificial Blood Cells Sale Price by Source (2017-2022)
  • 2.4 Artificial Blood Cells Segment by Application
    • 2.4.1 Cardiovascular Diseases
    • 2.4.2 Anemia
    • 2.4.3 Organ Transplant
    • 2.4.4 Others
  • 2.5 Artificial Blood Cells Sales by Application
    • 2.5.1 Global Artificial Blood Cells Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Artificial Blood Cells Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Artificial Blood Cells Sale Price by Application (2017-2022)

3 Global Artificial Blood Cells by Company

  • 3.1 Global Artificial Blood Cells Breakdown Data by Company
    • 3.1.1 Global Artificial Blood Cells Annual Sales by Company (2020-2022)
    • 3.1.2 Global Artificial Blood Cells Sales Market Share by Company (2020-2022)
  • 3.2 Global Artificial Blood Cells Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Artificial Blood Cells Revenue by Company (2020-2022)
    • 3.2.2 Global Artificial Blood Cells Revenue Market Share by Company (2020-2022)
  • 3.3 Global Artificial Blood Cells Sale Price by Company
  • 3.4 Key Manufacturers Artificial Blood Cells Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Artificial Blood Cells Product Location Distribution
    • 3.4.2 Players Artificial Blood Cells Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Artificial Blood Cells by Geographic Region

  • 4.1 World Historic Artificial Blood Cells Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Artificial Blood Cells Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Artificial Blood Cells Annual Revenue by Geographic Region
  • 4.2 World Historic Artificial Blood Cells Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Artificial Blood Cells Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Artificial Blood Cells Annual Revenue by Country/Region
  • 4.3 Americas Artificial Blood Cells Sales Growth
  • 4.4 APAC Artificial Blood Cells Sales Growth
  • 4.5 Europe Artificial Blood Cells Sales Growth
  • 4.6 Middle East & Africa Artificial Blood Cells Sales Growth

5 Americas

  • 5.1 Americas Artificial Blood Cells Sales by Country
    • 5.1.1 Americas Artificial Blood Cells Sales by Country (2017-2022)
    • 5.1.2 Americas Artificial Blood Cells Revenue by Country (2017-2022)
  • 5.2 Americas Artificial Blood Cells Sales by Source
  • 5.3 Americas Artificial Blood Cells Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Artificial Blood Cells Sales by Region
    • 6.1.1 APAC Artificial Blood Cells Sales by Region (2017-2022)
    • 6.1.2 APAC Artificial Blood Cells Revenue by Region (2017-2022)
  • 6.2 APAC Artificial Blood Cells Sales by Source
  • 6.3 APAC Artificial Blood Cells Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Artificial Blood Cells by Country
    • 7.1.1 Europe Artificial Blood Cells Sales by Country (2017-2022)
    • 7.1.2 Europe Artificial Blood Cells Revenue by Country (2017-2022)
  • 7.2 Europe Artificial Blood Cells Sales by Source
  • 7.3 Europe Artificial Blood Cells Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Artificial Blood Cells by Country
    • 8.1.1 Middle East & Africa Artificial Blood Cells Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Artificial Blood Cells Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Artificial Blood Cells Sales by Source
  • 8.3 Middle East & Africa Artificial Blood Cells Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Artificial Blood Cells
  • 10.3 Manufacturing Process Analysis of Artificial Blood Cells
  • 10.4 Industry Chain Structure of Artificial Blood Cells

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Artificial Blood Cells Distributors
  • 11.3 Artificial Blood Cells Customer

12 World Forecast Review for Artificial Blood Cells by Geographic Region

  • 12.1 Global Artificial Blood Cells Market Size Forecast by Region
    • 12.1.1 Global Artificial Blood Cells Forecast by Region (2023-2028)
    • 12.1.2 Global Artificial Blood Cells Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Artificial Blood Cells Forecast by Source
  • 12.7 Global Artificial Blood Cells Forecast by Application

13 Key Players Analysis

  • 13.1 Dextro-Sang Corporation
    • 13.1.1 Dextro-Sang Corporation Company Information
    • 13.1.2 Dextro-Sang Corporation Artificial Blood Cells Product Offered
    • 13.1.3 Dextro-Sang Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Dextro-Sang Corporation Main Business Overview
    • 13.1.5 Dextro-Sang Corporation Latest Developments
  • 13.2 BioPure Corporation
    • 13.2.1 BioPure Corporation Company Information
    • 13.2.2 BioPure Corporation Artificial Blood Cells Product Offered
    • 13.2.3 BioPure Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 BioPure Corporation Main Business Overview
    • 13.2.5 BioPure Corporation Latest Developments
  • 13.3 Sangart
    • 13.3.1 Sangart Company Information
    • 13.3.2 Sangart Artificial Blood Cells Product Offered
    • 13.3.3 Sangart Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Sangart Main Business Overview
    • 13.3.5 Sangart Latest Developments
  • 13.4 Northfield Laboratories
    • 13.4.1 Northfield Laboratories Company Information
    • 13.4.2 Northfield Laboratories Artificial Blood Cells Product Offered
    • 13.4.3 Northfield Laboratories Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Northfield Laboratories Main Business Overview
    • 13.4.5 Northfield Laboratories Latest Developments
  • 13.5 Baxter International
    • 13.5.1 Baxter International Company Information
    • 13.5.2 Baxter International Artificial Blood Cells Product Offered
    • 13.5.3 Baxter International Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Baxter International Main Business Overview
    • 13.5.5 Baxter International Latest Developments
  • 13.6 Dentritech
    • 13.6.1 Dentritech Company Information
    • 13.6.2 Dentritech Artificial Blood Cells Product Offered
    • 13.6.3 Dentritech Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Dentritech Main Business Overview
    • 13.6.5 Dentritech Latest Developments
  • 13.7 FluorO2 Therapeutics
    • 13.7.1 FluorO2 Therapeutics Company Information
    • 13.7.2 FluorO2 Therapeutics Artificial Blood Cells Product Offered
    • 13.7.3 FluorO2 Therapeutics Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 FluorO2 Therapeutics Main Business Overview
    • 13.7.5 FluorO2 Therapeutics Latest Developments
  • 13.8 Nuvox Pharma
    • 13.8.1 Nuvox Pharma Company Information
    • 13.8.2 Nuvox Pharma Artificial Blood Cells Product Offered
    • 13.8.3 Nuvox Pharma Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Nuvox Pharma Main Business Overview
    • 13.8.5 Nuvox Pharma Latest Developments
  • 13.9 Alpha Therapeutic Corporation
    • 13.9.1 Alpha Therapeutic Corporation Company Information
    • 13.9.2 Alpha Therapeutic Corporation Artificial Blood Cells Product Offered
    • 13.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Alpha Therapeutic Corporation Main Business Overview
    • 13.9.5 Alpha Therapeutic Corporation Latest Developments
  • 13.10 HemoBioTech
    • 13.10.1 HemoBioTech Company Information
    • 13.10.2 HemoBioTech Artificial Blood Cells Product Offered
    • 13.10.3 HemoBioTech Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 HemoBioTech Main Business Overview
    • 13.10.5 HemoBioTech Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Artificial Blood Cells. Industry analysis & Market Report on Artificial Blood Cells is a syndicated market report, published as Global Artificial Blood Cells Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Artificial Blood Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,840.16
5,680.32
3,411.12
6,822.24
564,701.40
1,129,402.80
308,611.20
617,222.40
Credit card Logo
Sample Question Discount Download PDF

Related Reports

Reason to Buy

  • Trusted By Leaders

    Top executives from leading companies purchase research reports from us. 

  • Shop With Confidence

    We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

  • Customer Centric

    Need assistance related to your research requirements? We are just a phone call or an email away.

  • Personalized Solutions

    Our experienced research specialists are here to help you locate the right reports for your need.

  • Secure Checkout

    Shop without being worried about safety & security of your transactions.
    •

Request for Sample of this report

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo